AA, aplastic anemia (n=33); MDS, myelodysplasia (n=57); HC-1, healthful control group-1 (< 55 yrs, n=29); HC-2, healthful control group-2 (55yrs, n =19); h-MDS, hypocellular MDS (n=14)
AA, aplastic anemia (n=33); MDS, myelodysplasia (n=57); HC-1, healthful control group-1 (< 55 yrs, n=29); HC-2, healthful control group-2 (55yrs, n =19); h-MDS, hypocellular MDS (n=14). equivalent clinical presentations, specific cytokine profiles had been noticed between aplastic anemia and hypocellular myelodysplasia. Upcoming studies concentrating on cytokines that better discriminate both of these entities such as…